Study of Artery Conditions of 'At-risk' Asian People Not on Lipid-lowering Drugs
NCT00970918 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2609
Last updated 2010-09-24
Summary
The purpose of this study is to obtain the distribution of measurements of the intima media thickness of carotid arteries in people with high cardiovascular risk.
Conditions
Interventions
- PROCEDURE
-
Measurement of the Carotid Intima Media thickness
one time, radiological procedure on both sides of the neck
- BIOLOGICAL
-
Blood sample testing for hs-CRP
one time, blood sample taking
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Guy Yeoman, MD · Asia Pacific Regional Office, AstraZeneca Singapore Pte Ltd 8 Wilkie Road, #07-01 Wilkie Edge, Singapore 228095
Study Design
- Allocation
- NA
- Purpose
- SCREENING
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 30 Years
- Max Age
- 69 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-10-31
- Primary Completion
- 2010-08-31
- Completion
- 2010-08-31
Countries
- China
- India
- Indonesia
- Malaysia
- Philippines
- South Korea
- Taiwan
- Thailand
- Vietnam
Study Locations
More Related Trials
-
ASA- and Clopidogrel-Responsiveness in Patients With Peripheral Arterial Occlusive Disease and Interventional Procedures
NCT00593762 ·Status: SUSPENDED
-
Transcranial Doppler (TCD) Assessment During Early Anti-thrombotic Therapy After Bioprosthetic Aortic Valve Replacement
NCT00465218 ·Status: COMPLETED
-
Aspirin Resistance in Coronary Artery Disease
NCT00753935 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Aspirin Resistance and Prognosis of Patients With Critical Limb Ischaemia
NCT01104441 ·Status: COMPLETED
-
Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization
NCT05347069 ·Status: RECRUITING ·Phase: PHASE4
-
A Study to Compare the Effects of Sarpogrelate Sustained Release /Aspirin Combination Therapy Versus Aspirin on Blood Viscosity in the Patients With Peripheral Arterial Disease and Coronary Artery Disease
NCT05730621 ·Status: COMPLETED ·Phase: PHASE4
-
Aspirin Treatment for Small Unruptured InTracranial Aneurysms With Ischemic cereBrovascuLar diseasE
NCT05907902 ·Status: UNKNOWN ·Phase: PHASE3
-
Coronary Artery Ectasia, Efficacy of Various Anti Thrombotic Regimens.
NCT05718531 ·Status: UNKNOWN ·Phase: PHASE3
-
Audit and Screening Study to Determine the Prevalence of Peripheral Arterial Disease
NCT00928629 ·Status: COMPLETED ·Phase: NA
-
Association of PeriOPerative Aspirin-ResisTance and CardioVascular Outcome
NCT04053894 ·Status: UNKNOWN
-
Perioperative Aspirin Response in Patients Undergoing Vascular Surgery
NCT03587324 ·Status: COMPLETED ·Phase: NA
-
Effect of Antithrombotic Treatment in Patients With Both Coronary Heart Disease and Atrial Fibrillation
NCT03051061 ·Status: UNKNOWN
-
Aspirin Responsiveness in Women at Risk for Cardiac Events
NCT00818337 ·Status: COMPLETED ·Phase: PHASE4
-
Optimized Antiplatelet Therapy on the Prognosis of ACS Patients With Non-predominant Coronary Artery Disease After PCI
NCT04338919 ·Status: UNKNOWN ·Phase: NA
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AZD3366 in Healthy Subjects, Japanese and Chinese Subjects
NCT04588727 ·Status: COMPLETED ·Phase: PHASE1
-
Thromboxane B2 and Platelet Function Testing as Measures of Aspirin Resistance in Hong Kong Chinese Patients
NCT04863053 ·Status: COMPLETED
-
Aspirin Twice Daily in Diabetic Patients With Coronary Artery Disease
NCT01617031 ·Status: COMPLETED
-
The Study on Profile and Genetic Factors of Aspirin Resistance (ProGEAR Study)
NCT00250380 ·Status: COMPLETED
-
Aspirin Dose and Atherosclerosis in Patients With Metabolic Syndrome
NCT00272311 ·Status: COMPLETED ·Phase: PHASE4
-
Japanese Primary Prevention Project With Aspirin
NCT00225849 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Assess the Drug Absorption Into the Blood After Administration of 3 Doses of AZD5718
NCT04087187 ·Status: COMPLETED ·Phase: PHASE1
-
AZD5718 Phase IIa Study to Evaluate Efficacy, Safety and Tolerability of Oral AZD5718 in Patients With Coronary Artery Disease (CAD).
NCT03317002 ·Status: COMPLETED ·Phase: PHASE2
-
Outcomes of Rivaroxaban and Aspirin in PAD After Endovascular Revascularization
NCT05308030 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Platelet Reactivity and MES During CEA
NCT01547039 ·Status: UNKNOWN
-
A Healthy Female and Male Volunteers Aspirin Study
NCT01448031 ·Status: COMPLETED ·Phase: PHASE1